Citations

Showing 10 of 108081 citations.

Epidemiology, risk factors, and outcomes of infections in patients undergoing liver transplantation for hilar cholangiocarcinoma
Ramanan, Poornima , Wilhelm, Mark , Dierkhising, Ross , Kremers, Walter K. , Rosen, Charles B. , Cummins, Nathan W. , Wilhelm, Mark P, Heimbach, Julie K. , Gores, Gregory J. , Razonable, Raymund R. , Kremers, Walter K

Mayo Clinic

Clinical Transplantation | June 2, 2017 | Volume: 31 | Issue: 8 | Pages: No page available

10.1111/ctr.13023 | PMID 28573685 Get It

AbstractThe epidemiology of infection after liver transplantation for hilar cholangiocarcinoma has not been systematically investigated. In this study of 124 patients, 255 infections occurred in 105 patients during the median follow‐up of 4.2 years. The median time to first infection was 15.1 weeks (IQR 1.6‐62.6). The most common sites were the abdomen, bloodstream, and musculoskeletal system. Risk factors for any post‐transplant infection were pre‐transplant VRE colonization (Hazard Ratio [HR] 1.9, P=.002), living donor transplantation (HR 6.6, P<.001), longer cold ischemia time (HR 1.05 per 10 minutes, P<.001), donor CMV seropositivity (HR 2.2, P<.001), hepatic artery thrombosis (HR 2.6, P=.005), biliary stricture (HR 3.8, P=.002), intra‐abdominal fluid collection (HR 4.2, P<.001), and re‐operations within 1 month after transplantation (HR 1.7, P=.020). Abdominal infections were independently associated with hemodialysis requirement within 1 month after transplantation (HR 5.6, P=.006), hepatic artery thrombosis (HR 3.3, P=.007), biliary stricture (HR 5.2, P<.001), and abdominal fluid collection (HR 3.7, P=.0002). Bloodstream infections were independently associated with allograft ischemia (HR 17.8, P<.001), biliary stricture (HR 6.5, P=.005), and recipient VRE colonization (HR 4, P<.001). Abdominal infections (HR 2.3, P=.02) and Clostridium difficile infections (HR 4.6, P=.01) were independently associated with increased mortality.
Bilateral Middle Cerebral Artery Occlusion In Rapid Succession During Thrombolysis
Braksick, Sherri A. , Robinson, Christopher P. , Wijdicks, Eelco F. M.

Mayo Clinic

The Neurohospitalist | June 2, 2017 | Volume: 8 | Issue: 2 | Pages: 102-103

10.1177/1941874417712159 | PMID 29623161 Get It

Percutaneous laser ablation of the feeding vessel in pulmonary sequestration or hybrid lesions
Kilby, Mark D. , Ruano, Rodrigo

Mayo Clinic

Ultrasound in Obstetrics & Gynecology | June 2, 2017 | Volume: 49 | Issue: 6 | Pages: 810-811

10.1002/uog.17506 | PMID 28573774 Get It

Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease
Bielinski, Suzette J. , Berardi, Cecilia , Decker, Paul A. , Bell, Elizabeth J. , Pankow, James S. , Sale, Michèle M. , Tang, Weihong , Hanson, Naomi Q., Wassel, Christina L. , Budoff, Matthew J. , Sicotte, Hugues , Tsai, Michael Y. , de Andrade, Mariza, Decker, Paul A. , Larson, Nicholas B. , Andrade, Mariza de , Polak, Joseph F. , Bielinski, Suzette , Budoff, Matthew , Pankow, James S , Tang, Weihong

Mayo Clinic

Heart | June 1, 2017 | Volume: 103 | Issue: 15 | Pages: 1185-1193

10.1136/heartjnl-2016-310450 | PMID 28572400 Get It

Objective To determine if hepatocyte growth factor (HGF), a promising biomarker of coronary heart disease (CHD) given its release into circulation in response to endothelial damage, is associated with subclinical and clinical CHD in a racial/ethnic diverse population. Methods HGF was measured in 6738 participants of the Multi-Ethnic Study of Atherosclerosis (MESA). Highest mean HGF values (pg/mL) were observed in Hispanic, followed by African, non-Hispanic white, then Chinese Americans. Results In all races/ethnicities, HGF levels were associated with older age, higher systolic blood pressure (SBP) and body mass index, lower high-density lipoprotein, diabetes and current smoking. In fully adjusted models, each SD higher HGF was associated with an average increase in coronary artery calcium (CAC) of 55 Agatston units for non-Hispanic whites (p<0.001) and 51 Agatston units for African-Americans (p=0.007) but was not in the other race/ethnic groups (interaction p=0.02). There were 529 incident CHD events, and CHD risk was 41% higher in African (p<0.001), 17% in non-Hispanic white (p=0.026) and Chinese (p=0.36), and 6% in Hispanic Americans (p=0.56) per SD increase in HGF. Conclusion In a large and diverse population-based cohort, we report that HGF is associated with subclinical and incident CHD. We demonstrate evidence of racial/ethnic heterogeneity within these associations, as the results are most compelling in African-Americans and non-Hispanic white Americans. We provide evidence that HGF is a biomarker of atherosclerotic disease that is independent of traditional risk factors.
Development and validation of a nomogram to estimate the pretest probability of cancer in Chinese patients with solid solitary pulmonary nodules: A multi‐institutional study
She, Yunlang , Zhao, Lilan , Dai, Chenyang , Ren, Yijiu , Jiang, Gening , Xie, Huikang , Zhu, Huiyuan , Sun, Xiwen , Shi, Shunbin, Shi, Weirong, Xie, Dong , Chen, Chang , Yang, Ping , Chen, Yongbing , Yu, Bing

Mayo Clinic

Journal of Surgical Oncology | June 1, 2017 | Volume: 116 | Issue: 6 | Pages: 756-762

10.1002/jso.24704 | PMID 28570780 Get It

ObjectivesTo develop and validate a nomogram to estimate the pretest probability of malignancy in Chinese patients with solid solitary pulmonary nodule (SPN).Materials and MethodsA primary cohort of 1798 patients with pathologically confirmed solid SPNs after surgery was retrospectively studied at five institutions from January 2014 to December 2015. A nomogram based on independent prediction factors of malignant solid SPN was developed. Predictive performance also was evaluated using the calibration curve and the area under the receiver operating characteristic curve (AUC).ResultsThe mean age of the cohort was 58.9 ± 10.7 years. In univariate and multivariate analysis, age; history of cancer; the log base 10 transformations of serum carcinoembryonic antigen value; nodule diameter; the presence of spiculation, pleural indentation, and calcification remained the predictive factors of malignancy. A nomogram was developed, and the AUC value (0.85; 95%CI, 0.83‐0.88) was significantly higher than other three models. The calibration cure showed optimal agreement between the malignant probability as predicted by nomogram and the actual probability.ConclusionsWe developed and validated a nomogram that can estimate the pretest probability of malignant solid SPNs, which can assist clinical physicians to select and interpret the results of subsequent diagnostic tests.
Comparison of the vasodilatory effects of sodium nitroprusside vs. nitroglycerin
Ranadive, Sushant M. , Eugene, Andy R., Nicholson, Wayne T. , Joyner, Michael J. , Ranadive, Sushant M. , Dillon, Gabrielle, Eugene, Andy R., Dillon, Gabrielle A. , Joyner, Michael J , Ranadive, Sushant

Mayo Clinic

Journal of Applied Physiology | June 1, 2017 | Volume: 123 | Issue: 2 | Pages: 402-406

10.1152/japplphysiol.00167.2017 | PMID 28572495 Get It

The vasodilatory mechanism of Nntroglycerin (NTG) is similar to sodium nitroprusside (SNP) in regard to action on guanosine 3′5′-monophosphate (cyclic GMP) via nitric oxide. However, it is unknown whether NTG can achieve the same magnitude of vasodilation in the forearm as SNP. Therefore, the purpose of the study was to evaluate the differences in forearm blood flow (FBF) and forearm vascular conductance (FVC) during escalating infusions of NTG vs. SNP at similar concentration doses and rates. We measured FBF using venous occlusion plethysmography (VOP) and Doppler ultrasound in eight young, healthy participants (mean age = 28 ± 2 yr) during four forearm volume (FAV)-specific doses (0.25, 0.5, 1, and 2 µg·100 ml FAV−1·min−1) of SNP and NTG infused via a brachial artery catheter. There was a significant difference in FVC of SNP vs. NTG only at the higher doses, as measured by VOP (14.9 ± 1.4 and 18.3 ± 1.5 vs. 11.6 ± 1.2 and 12.5 ± 1.2 ml/dl FAV−1·min−1·100 mmHg−1). FVC as measured by Doppler ultrasound unadjusted for FAV was significantly different at the lowest and the higher two doses of SNP compared with NTG (202.1 ± 25.8, 329.4 ± 46.7, and 408 ± 63.5 vs. 142.9 ± 22.4, 217.2 ± 18.8, and 247.5 ± 18.2 ml·min−1·100 mmHg−1). SNP induces significantly higher vasodilatory actions compared with NTG. However, NTG is comparable in eliciting equivalent vasodilator effects to SNP during low concentration doses when measured by VOP. Importantly, for forearm pharmacology studies, NTG can elicit marked endothelium-independent forearm vasodilation. NEW & NOTEWORTHY We compared the vasodilatory capacities of NTG vs. SNP at similar concentration doses and rates into the forearm. Based on the results of the study, it may be feasible to use intra-arterial NTG as a measure of endothelial-independent vasodilator in research studies. However, NTG dosing may need to be higher if used as an endothelial-independent vasodilator due to significant differences in the vasodilatory effects during higher doses of SNP compared with NTG.
MR Elastography Demonstrates Unique Regional Brain Stiffness Patterns in Dementias
ElSheikh, Mona M., Arani, Arvin , Perry, Avital , Meyer, Fredric B. , Savica, Rodolfo , ElSheikh, Mona, Boeve, Bradley F. , Ehman, Richard L. , Huston, John , Arani, Arvin

Mayo Clinic

American Journal of Roentgenology | June 1, 2017 | Volume: 209 | Issue: 2 | Pages: 403-408

10.2214/ajr.16.17455 | PMID 28570101 Get It

Concurrent Electroconvulsive Therapy and Bupropion Treatment
Takala, Christopher R., Leung, Jonathan G. , Murphy, Lauren L., Geske, Jennifer R. , Palmer, Brian A. , Leung, Jonathan G , Geske, Jennifer

Mayo Clinic

The Journal of ECT | June 1, 2017 | Volume: 33 | Issue: 3 | Pages: 185-189

10.1097/yct.0000000000000423 | PMID 28570500 Get It

Background Bupropion is associated with a dose-dependent increased risk of seizures. Use of concomitant bupropion and electroconvulsive therapy (ECT) remains controversial because of an increased risk of prolonged seizures. This is the first systematic evaluation of the effect of bupropion on ECT. Methods A case group (n = 119), patients treated with concomitant ECT and bupropion, was compared with an age and gender frequency–matched control group (n = 261), treated with only ECT. Electroconvulsive therapy treatment data including seizure length, number of treatments, and concurrent medications were extracted. Longitudinal mixed models examined ECT versus ECT + bupropion group differences over the course of treatments measured by seizure duration (electroencephalogram [EEG] and motor). Multivariable models examined the total number of treatments and first and last seizure duration. All models considered group differences with ECT treatment measures adjusted for age, gender, benzodiazepine treatment, lead placement, and setting. Results Electroconvulsive therapy treatment with bupropion led to shorter motor seizure duration (0.047) and EEG seizure duration (P = 0.001). The number of ECT treatments (7.3 vs 7.0 treatments; P = 0.23), respectively, or the probability of a prolonged seizure (P = 0.15) was not significantly different. Benzodiazepine use was significantly more common in control subjects (P = 0.01). Limitations This is a retrospective analysis limited in part by unavailable variables (seizure threshold, nature of EEG and motor seizure monitoring, type of ECT device, dosing and formulation of bupropion, and duration of the current depressive illness). Conclusions This study revealed a significantly shorter duration in seizure length with ECT + concomitant bupropion, but not in the number of required treatments in those treated compared with ECT without bupropion. There remains a critical need to reevaluate the efficacy of concomitant use of psychotropic medications + ECT.
Systematic Review of the Outcomes of Surgical Treatment of Prostate Metastases to the Spine
Molina, Camilo A. , Fourney, Daryl R. , Fisher, Charles G. , Gokaslan, Ziya L. , Schmidt, Meic H. , Rhines, Laurence D. , Fehlings, Michael G. , Laufer, Ilya , Patel, Shreyaskumar , Rampersaud, Y. Raja , Reynolds, Jeremy , Chou, Dean , Mendel, Ehud , Weber, Michael H. , Sciubba, Daniel M. , Reynolds, Jeremy , Clarke, Michelle J. , Bettegowda, Chetan , Fehlings, Michael G , Reynolds, Jeremy

Mayo Clinic

Global Spine Journal | June 1, 2017 | Volume: 7 | Issue: 5 | Pages: 460-468

10.1177/2192568217710911 | PMID 28811991 Get It

Study Design: Systematic review. Objective: Surgical decompression and reconstruction of symptomatic spinal metastases has improved the quality of life in cancer patients. However, most data has been collected on cohorts of patients with mixed tumor histopathology. We systematically reviewed the literature for prognostic factors specific to the surgical treatment of prostate metastases to the spine. Methods: A systemic review of the literature was conducted to answer the following questions: Question 1. Describe the survival and functional outcomes of surgery or vertebral augmentation for prostate metastases to the spine. Question 2. Determine whether overall tumor burden, Gleason score, preoperative functional markers, and hormonal naivety favor operative intervention. Question 3. Establish whether clinical outcomes vary with the evolution of operative techniques. Results: A total of 16 studies met the preset inclusion criteria. All included studies were retrospective series with a level of evidence of IV. Included studies consistently showed a large effect of hormone-naivety on overall survival. Additionally, studies consistently demonstrated an improvement in motor function and the ability to maintain/regain ambulation following surgery resulting in moderate strength of recommendation. All other parameters were of insufficient or low strength. Conclusions: There is a dearth of literature regarding the surgical treatment of prostate metastases to the spine, which represents an opportunity for future research. Based on existing evidence, it appears that the surgical treatment of prostate metastases to the spine has consistently favorable results. While no consistent preoperative indicators favor nonoperative treatment, hormone-naivety and high Karnofsky performance scores have positive effects on survival and clinical outcomes.
Zebrafish and the Cancer Moonshot
Schimmenti, Lisa A. , Schimmenti, Lisa A

Mayo Clinic

Zebrafish | June 1, 2017 | Volume: 14 | Issue: 4 | Pages: 390-392

10.1089/zeb.2017.1450 | PMID 28570143 Get It